Last reviewed · How we verify
NCT03745703
MOCHA Moving Forward: a CBPR Investigation of Chronic Disease Prevention in Older, Low-income African-American Men
NA trial testing MOCHA in Chronic Disease of Cardiovascular System in 261 participants. Completed in 31 July 2021.
31 July 2021
Quick facts
| Lead sponsor | University of Massachusetts, Amherst |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 261 |
| Start date | 3 June 2016 |
| Primary completion | 31 July 2021 |
| Estimated completion | 31 July 2021 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- MOCHA
Conditions studied
- Chronic Disease of Cardiovascular System — all drugs for Chronic Disease of Cardiovascular System →
- Multiple Chronic Conditions — all drugs for Multiple Chronic Conditions →
- Chronic Disease — all drugs for Chronic Disease →
Sponsor
University of Massachusetts, Amherst
Who can join
Adults 35 to 70, male only, with Chronic Disease of Cardiovascular System or Multiple Chronic Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of the research is to discover how to reduce chronic disease health disparities among older (ages 35-70) low-income African-American men more effectively. To achieve this goal, the investigators are conducting formative exploratory research with middle-aged, low-income African-American men; testing two versions of a novel community-developed intervention, MOCHA and MOCHA+ (where MOCHA+ is a modified version of the "standard" MOCHA program, modified to incorporate narrative communication strategies); and advancing the development of a Minority Stress Model through statistical modelling to test the relative contributions of hypothesized explanatory variables identified in the formative research phase of the project.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Men of Color Health Awareness intervention: changes in adrenocortical activity assessed using fingernail cortisol.
Meyer JS, Markham J, Scott L, Valdez LA, et al · · 2025 · PMID 40717953 · DOI 10.3389/fpubh.2025.1526636
Verify or expand the search:
- PubMed search for NCT03745703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MOCHA
Trials testing the same drug.
- NCT03229928 — Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge · completed
Other University of Massachusetts, Amherst trials
Trials by the same sponsor.
- NCT07211373 — Advancing Student Suicide Interventions With Scalable Technologies · NA · enrolling by invitation
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT07016555 — Burning Mouth Syndrome: Symptoms and Management · EARLY_PHASE1 · recruiting
- NCT06412016 — Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity · NA · active not recruiting
- NCT06399939 — The Function of Biphasic Sleep in Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03745703 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
- Last refreshed: 8 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing